|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2′-Deoxy-3′,5′-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-N-[(11S,12R,13S,14S)-11,12,13-tris(acetyloxy)-11,12,13,14-tetrahydrodibenzo[def,p]chrysen-14-yl]adenosine
NC4026831093365-30-0
-
|
|
|
|
|
2′-Deoxy-3′,5′-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-N-[(11R,12S,13R,14R)-11,12,13-tris(acetyloxy)-11,12,13,14-tetrahydrodibenzo[def,p]chrysen-14-yl]adenosine
NC4026821093365-31-1
-
|
|
|
|
|
2′-Deoxy-3′,5′-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-N-[(11R,12S,13R,14S)-11,12,13-tris(acetyloxy)-11,12,13,14-tetrahydrodibenzo[def,p]chrysen-14-yl]adenosine
NC4026811093365-37-7
-
|
|
|
|
|
2′-Deoxy-3′,5′-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-N-[(11S,12R,13S,14R)-11,12,13-tris(acetyloxy)-11,12,13,14-tetrahydrodibenzo[def,p]chrysen-14-yl]adenosine
NC4026801093365-39-9
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|